Innovatiefonds Noord-Holland

Phosphoenix is a neurotechnology company that specializes in developing innovative solutions for vision restoration. Originating from the NESTOR program, which received support from the Netherlands Organisation for Scientific Research, the company was founded by a team of accomplished neuroscientists, electronic engineers, and entrepreneurs. Phosphoenix focuses on creating a chronically implanted wireless device that bypasses the eyes and interfaces directly with the brain. This technology is designed to restore functional vision for individuals who have lost their sight, allowing users to recognize objects, navigate independently, and improve their overall quality of life. By leveraging fundamental insights from neuroscience, Phosphoenix aims to translate these advancements into practical clinical applications.

Phosphoenix is a neurotechnology company that specializes in developing innovative solutions for vision restoration. Originating from the NESTOR program, which received support from the Netherlands Organisation for Scientific Research, the company was founded by a team of accomplished neuroscientists, electronic engineers, and entrepreneurs. Phosphoenix focuses on creating a chronically implanted wireless device that bypasses the eyes and interfaces directly with the brain. This technology is designed to restore functional vision for individuals who have lost their sight, allowing users to recognize objects, navigate independently, and improve their overall quality of life. By leveraging fundamental insights from neuroscience, Phosphoenix aims to translate these advancements into practical clinical applications.

ATRO Medical B.V., based in Nijmegen, the Netherlands, specializes in the development of anatomically shaped polymer meniscus implants, specifically the Trammpolin. This innovative prosthesis is designed to replace damaged menisci, restoring their protective function by acting as a joint spacer and shock absorber. The Trammpolin mimics the natural meniscus, facilitating adequate load distribution within the knee joint, which can provide significant relief for osteoarthritis patients suffering from severe pain. ATRO Medical emerged as a spin-out from DSM and Radboudumc, leveraging expertise from a public-private collaboration initiated in 2010 that involved various universities, private companies, and support from the Dutch government. This collaborative effort has been instrumental in the design and development of the Trammpolin prototype.

Digi.Bio develops software and automation platforms for the healthcare and life sciences sector. The company creates digital microfluidics and electrowetting-based automation software to streamline multistep liquid handling in laboratories, replacing traditional pipetting robots. It operates a lab-on-a-chip and computational platform that analyzes cell therapies, evaluating performance and outcomes at the single-cell level to deliver high-content results quickly with minimal material waste. The company uses artificial intelligence to rapidly and precisely manipulate droplets on a microscale, enabling automated workflows for medical and pharmaceutical applications and the scaling of bioengineering processes. It is based in Amsterdam, Netherlands.

Confocal.nl is aiming to innovate the microscopy industry with their plug-and-play feature confocal microscopes including the re-scan invention (Re-scan Confocal Microscope). Their new RCM-microscope has an improved resolution and strongly improved sensitivity as compared to most confocal microscopes. It will be available as a highly affordable, customised device, which is ideal for labs with specific interests, or as an upgrade for existing wide-field fluorescence microscopes. Their goal is an open-architecture system that can be customised at need, and is platform- and software independent.

Dyme is a personal finance platform that consolidates all subscriptions in one place, enabling users to manage, cancel, and switch services from a single app. It uses financial data and machine learning to provide a clear overview of income and expenses, offer insights into spending, and assist with renegotiating contracts to help users reduce fixed costs.

Amsterdam Scientific Instruments B.V. is a research and manufacturing company based in Amsterdam, the Netherlands, established in 2011. It specializes in advanced camera systems designed for scientific applications, focusing on neutron detection, electron imaging, and X-ray detector technology. The company develops sophisticated hybrid-pixel detectors, including single photon counting devices and Medipix or Timepix-based systems, which are utilized in various fields such as electron microscopy, mass spectrometry, X-ray imaging, and neutron imaging. By providing innovative alternatives to standard scientific detectors, Amsterdam Scientific Instruments empowers the global scientific community to explore and advance their research into the properties and dynamics of X-rays, photons, electrons, neutrons, and ions.